| Names | |
|---|---|
| Preferred IUPAC name 2-(Furan-2-yl)-7-[3-(4-methoxyphenyl)propyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine | |
| Other names SCH-442,416 | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| UNII | |
| |
| |
| Properties | |
| C20H19N7O2 | |
| Molar mass | 389.410 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
SCH-442,416 is a highly selectiveadenosineA2a subtype receptorantagonist. It is widely used in its11Cradiolabelled form to map the distribution of A2a receptors in the brain, where they are mainly found in thestriatum,nucleus accumbens, andolfactory tubercle.[1] Given its distribution in the brain, A2a receptors have been investigated for the treatment of various neurological disorders, and SCH-442,416 has shown promise in treatment ofdepression,[2]Parkinson's disease,[3] andcatalepsy.[4]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byadding missing information. |